Gastrointestinal Health News and Research

Latest Gastrointestinal Health News and Research

Surgical lung injury prediction model can help identify patients at high risk of ALI

A new study in the July issue of Anesthesiology helped developed a model that could determine which patients are at high risk of developing acute lung injury.

23 Jun 2011

Telaprevir drug shows promise in curing hepatitis C infection

The drug telaprevir (Incivek) provides a dramatic improvement in the treatment of the most common form of hepatitis C infection, says an international team of investigators led by Dr. Ira M. Jacobson of NewYork-Presbyterian Hospital/Weill Cornell Medical Center.

23 Jun 2011

Simple non-invasive breath test could accurately detect vitamin B12 deficiency

Researchers have developed a new test to detect the levels of vitamin B12 using your breath, allowing for a cheaper, faster, and simpler diagnosis that could help to avoid the potentially fatal symptoms of B12 deficiency.

23 Jun 2011

FDA approves ProStrakan's Rectiv for pain associated with anal fissures

ProStrakan Group plc, a subsidiary of Kyowa Hakko Kirin Co. Ltd., and an international specialty pharmaceutical company, today announces that it has received approval from the U.S. Food and Drug Administration (FDA) for Rectiv™ (nitroglycerin) Ointment 0.4 % for the treatment of moderate to severe pain associated with chronic anal fissures.

22 Jun 2011

Veritract to develop 'Smart Feeding Tube' with live camera and steering mechanism

Feeding tubes are not as harmless as they seem. Every year in the U.S. over 40,000 feeding tubes are mistakenly placed into a patient's lungs, which results in an estimated 6,000 deaths. But a University of Utah startup company, Veritract Inc., hopes to end these risks by making the placement of feeding tubes much safer and faster.

20 Jun 2011

UCLA's new center to explore links between brain, digestive system in chronic disorders

Investigators at UCLA's Center for Neurobiology of Stress have been studying the links between the brain and digestive system in the development and treatment of common chronic digestive disorders in adults and children.

16 Jun 2011

ClinTec opens fully registered offices in China, Singapore and Thailand for clinical research

UK based Global Clinical Research Organisation (CRO), ClinTec International has continued its international expansion by opening fully registered offices in China, Singapore and Thailand - consolidating its presence in the Asia Pacific region.

16 Jun 2011

MRE reduces ionizing radiation exposure, detects Crohn's disease as reliably as CT

A new study from Rhode Island Hospital has found that MR enterography (MRE) without the use of an anti-peristaltic agent were as reliable as CT enterography (CTE) in determining the presence of Crohn's disease.

16 Jun 2011

Children's Medical Center to open new $21M Specialty Care Center in Southlake

Children's Medical Center will debut its new Specialty Care Center in Southlake on June 18, a $21 million expansion which will serve children in one of the state's fastest-growing cities and the surrounding communities.

16 Jun 2011

USPTO issues patent to EndoSphere's noninvasive device for treatment of obesity

EndoSphere Inc., a medical technology company that holds 23 U.S. and international issued and pending patents, announced today that the U.S. Patent and Trademark Office has issued the company a patent covering the use of its endoscopically implantable devices for the treatment of metabolic diseases, including obesity and type 2 diabetes.

16 Jun 2011

Liver stiffness measurement could replace liver biopsy for evaluation of hepatitis C

Non-invasive tests for liver fibrosis, such as liver stiffness measurement or the FibroTest, can predict survival of patients with chronic hepatitis C, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.

15 Jun 2011

Alios, Vertex sign worldwide license agreement to develop new hepatitis C combination medicines

Vertex Pharmaceuticals Incorporated and Alios BioPharma, Inc. today announced an exclusive worldwide licensing agreement that will add two distinct nucleotide analogues to Vertex's hepatitis C portfolio.

13 Jun 2011

German hospital adopts Luminex new diagnostic assay to manage current E.coli outbreak

Luminex Corporation and the Kliniken der Stadt Koln, Institute of Pathology and Institute for Hygiene today announced that Luminex's newly released xTAG Gastrointestinal Pathogen Panel (GPP) is being used successfully as a first-line screen for patients at Kliniken der Stadt Koln suspected of having an E. coli infection.

From Luminex 10 Jun 2011

AGA honors outstanding high school students with 2011 research fellowship awards

The American Gastroenterological Association (AGA) Research Foundation has announced the 2011 Student Research Fellowship Award recipients. Funded by The Eli and Edythe Broad Foundation, the awards are intended to stimulate interest in research careers in digestive diseases.

10 Jun 2011

Repligen total revenue increases 30% to $27,291,000 for fiscal year 2011

Repligen Corporation today reported results for the fourth quarter and fiscal year 2011, ended March 31, 2011.

9 Jun 2011

Hepatitis C virus (HCV)-associated liver disease after liver transplantation

Hepatitis C virus (HCV)-associated liver disease continues to be the most common indication for liver transplantation (LT) in the United States accounting for nearly 50% of all liver transplants. Recurrence is universal in patients viremic at the time of transplantation with histological hepatitis developing in the majority of patients. Although the natural history of recurrent HCV is difficult to predict, it is widely accepted that cirrhosis from recurrent HCV occurs in up to 30% of patients within five years of transplantation.

8 Jun 2011

Topline results from 4SC vidofludimus Phase IIb trial against rheumatoid arthritis

4SC AG, a discovery and development company of targeted small molecule drugs for autoimmune diseases and cancer, today announced topline results from its randomised, double-blind, placebo-controlled Phase IIb clinical trial COMPONENT in RA.

8 Jun 2011

Overweight increases risk of liver cirrhosis in men

Overweight carries a greatly increased risk of cirrhosis of the liver in men, reveals a new study from the Sahlgrenska Academy. "Given the increasing problem of overweight in Sweden, there is reason to fear that more people will develop cirrhosis of the liver," says Jerzy Kaczynski, docent at the University of Gothenburg and doctor at Sahlgrenska University Hospital.

8 Jun 2011

Hepatitis C patients with chronic liver disease may benefit from drinking coffee during treatment

Advanced hepatitis C patients with chronic liver disease may benefit from drinking coffee during treatment, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.

8 Jun 2011

Shire Canada receives expanded indication for MEZAVANT for treatment of ulcerative colitis

Shire Canada Inc., a division of Shire plc, the global specialty biopharmaceutical company, is proud to announce that MEZAVANT® (mesalamine delayed and extended release tablets), the first and only once-daily mesalamine indicated for the induction of clinical and endoscopic remission in patients with mild-to-moderate, active ulcerative colitis (UC), has received an expanded indication to include maintenance of clinical and endoscopic remission (mucosal healing) in patients with ulcerative colitis.

7 Jun 2011

Gastrointestinal Health News and Research

Latest Gastrointestinal Health News and Research

Surgical lung injury prediction model can help identify patients at high risk of ALI

Telaprevir drug shows promise in curing hepatitis C infection

Simple non-invasive breath test could accurately detect vitamin B12 deficiency

FDA approves ProStrakan's Rectiv for pain associated with anal fissures

Veritract to develop 'Smart Feeding Tube' with live camera and steering mechanism

UCLA's new center to explore links between brain, digestive system in chronic disorders

ClinTec opens fully registered offices in China, Singapore and Thailand for clinical research

MRE reduces ionizing radiation exposure, detects Crohn's disease as reliably as CT

Children's Medical Center to open new $21M Specialty Care Center in Southlake

USPTO issues patent to EndoSphere's noninvasive device for treatment of obesity

Liver stiffness measurement could replace liver biopsy for evaluation of hepatitis C

Alios, Vertex sign worldwide license agreement to develop new hepatitis C combination medicines

German hospital adopts Luminex new diagnostic assay to manage current E.coli outbreak

AGA honors outstanding high school students with 2011 research fellowship awards

Repligen total revenue increases 30% to $27,291,000 for fiscal year 2011

Hepatitis C virus (HCV)-associated liver disease after liver transplantation

Topline results from 4SC vidofludimus Phase IIb trial against rheumatoid arthritis

Overweight increases risk of liver cirrhosis in men

Hepatitis C patients with chronic liver disease may benefit from drinking coffee during treatment

Shire Canada receives expanded indication for MEZAVANT for treatment of ulcerative colitis

Microbiology eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Gastrointestinal Health News and Research

Latest Gastrointestinal Health News and Research

Microbiology eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in